MedPath

UNIPHARM (HONG KONG) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

29

PPB:29

Drug Approvals

TAMSULOSIN HYDROCHLORIDE MODIFIED RELEASE CAPSULES 0.4MG

Approval Date
Jan 12, 2021
PPB

ROSUVASTATIN TABLETS 5MG

Approval Date
Aug 25, 2020
PPB

ROSUVASTATIN TABLETS 20MG

Approval Date
Aug 25, 2020
PPB

ROSUVASTATIN TABLETS 10MG

Approval Date
Aug 25, 2020
PPB

TENOFOVIR DISOPROXIL FUMARATE TABLETS 300MG

Approval Date
Nov 20, 2019
PPB

REMUS OINTMENT 0.03%W/W

Approval Date
Jul 16, 2012
PPB

REMUS OINTMENT 0.1%W/W

Approval Date
Jul 16, 2012
PPB

AMBROX 75 SR CAP 75MG

Approval Date
Dec 24, 2010
PPB

KAMIREN XL TAB 4MG

Approval Date
Nov 25, 2010
PPB

NAC EFFERVESCENT TAB 600MG

Approval Date
Oct 20, 2010
PPB
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.